Table 4 Blood Count and Biochemical Profile of the participants at discharge [median (IQR)].

From: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

Factor

Favipiravir

Hydroxychloroquine

Standard Care

P-value

N

54

51

52

 

Sodium mmolL, median (IQR)

138.0 (137.0, 140.5)

138.7 (138.0, 141.0)

139.0 (137.0, 140.3)

0.33

Potassium mmol, median (IQR)

4.3 (4.1, 4.6)

4.3 (4.1, 4.7)

4.3 (4.1, 4.7)

0.69

Urea mmolL, median (IQR)

4.1 (3.6, 5.4)

4.1 (3.5, 5.3)

4.6 (4.0, 5.7)

0.10

Creatinine umolL, median (IQR)

58.0 (50.1, 66.2)

56.8 (49.0, 68.8)

56.7 (49.0, 65.4)

0.98

Hemoglobin mg/dl, median (IQR)

13.0 (11.5, 14.1)

13.7 (12.0, 14.9)

13.4 (12.0, 14.6)

0.38

White blood count median (IQR)

5.6 (4.1, 6.7)

5.4 (4.4, 7.1)

5.3 (4.0, 7.2)

0.85

Neutrophil Count, median (IQR)

3.0 (2.0, 4.0)

3.3 (2.0, 4.0)

3.0 (2.0, 4.0)

0.98

Lymphocyte Count, median (IQR)

1.5 (1.1, 2.0)

1.5 (1.2, 2.0)

1.5 (1.1, 1.8)

0.69

Platelet Count, median (IQR)

258 (209, 318)

217 (180, 284)

243 (176, 272)

0.029

Lactate dehydrogenase mmolL, median (IQR)

212 (196, 256)

197 (163, 265)

240 (175, 304)

0.19

C-reactive protein mmolL, median (IQR)

16.6 (4.1, 47.5)

9.5 (3.9, 25.5)

16.7 (5.8, 39.7)

0.26

Uric Acid mmolL, median (IQR)

313 (256, 370)

247 (185, 315)

265 (198, 337)

0.004

Ferritin mmolL, median (IQR)

128 (66, 383)

250 (76, 460)

241 (100, 590)

0.34

DDimer mmolL, median (IQR)

0.4 (0.3, 0.8)

0.5 (0.3, 0.9)

0.5 (0.3, 0.9)

0.63

Lactate mmolL, median (IQR)

1.3 (1.1, 1.8)

1.7 (1.3, 2.0)

1.7 (1.3, 2.3)

0.11

Bilirubin umol/l, median (IQR)

6.2 (4.9, 9.5)

6.8 (5.5, 9.9)

6.8 (5.2, 9.8)

0.36

  1. *Significance values are based on Kruskal–Wallis test.